COMMUNIQUÉS West-GlobeNewswire

Bone Therapeutics annonce les nominationsd’Olivier Godeaux au poste de Chief Medical Officer et de Benoit Moreaux au poste de Chief Scientific and Technology Officer
12/03/2019
Communiqué de presse Gosselies, Belgique, le 12 mars 2019, 8h00 CET - BONE THERAPEUTICS (Euronext Bruxelles et Paris : BOTHE, éligible PEA-PME), société de thérapie cellulaire osseuse qui répond à d’importants besoins [...]
Biogen Enters Into an Agreement to Sell Its Large-Scale Biologics Manufacturing Site in Hillerød, Denmark to Fujifilm
12/03/2019
Approximately 800 employees at Hillerød site expected to continue employment under Fujifilm ownership Biogen will enter into manufacturing services agreements with Fujifilm to supply TYSABRI ® and third-party products [...]
Biocartis Group NV: Biocartis and Bristol-Myers Squibb Sign Collaboration Agreement for MSI Testing with Immuno-Oncology Therapies
12/03/2019
PRESS RELEASE 12 March 2019, 07:00 CET Biocartis and Bristol-Myers Squibb Sign Collaboration Agreement for MSI Testing with Immuno-Oncology Therapies Mechelen, Belgium, 12 March 2019 - Biocartis Group NV (the 'Company' [...]
Santhera Completes Patient Enrollment in Phase IV Long-term Study with Raxone® for the Treatment of Leber's Hereditary Optic Neuropathy
12/03/2019
Pratteln, Switzerland, March 12, 2019 - Santhera Pharmaceuticals (SIX: SANN) announces that it has completed patient enrollment in the ongoing Phase IV study (LEROS) with Raxone® (idebenone) for the treatment of Leber's [...]
Biophytis Reports Annual 2018 Financial Results and Provides Operational Update
12/03/2019
Clinical execution and advancement of our SARA program, including initiation of the SARA-INT Phase 2b clinical trial for sarcopenia Launch of our MYODA program for Duchenne muscular dystrophy (DMD) Expansion of [...]
Innate Pharma: Jennifer Butler appointed as Executive VP, General Manager, US
12/03/2019
Innate Pharma announces the appointment of Jennifer Butler as Executive Vice President, General Manager, US Commercial industry leader with immuno-oncology product launch experience joins Innate’s Executive Committee [...]
Innate Pharma: Jennifer Butler nommée VP exécutif, DG de la filiale américaine
12/03/2019
INNATE PHARMA ANNONCE LA NOMINATION DE JENNIFER BUTLER EN TANT QUE VICE-PRÉSIDENT EXECUTIF, DIRECTEUR GÉNÉRAL DE LA FILIALE AMÉRICAINE Un leader commercial du secteur avec de l’expérience dans les lancements de produits [...]
Guardant Health to Present at the 39th Annual Cowen Health Care Conference
12/03/2019
REDWOOD CITY, Calif., March 11, 2019 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq:GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, [...]
Guardant Health to Report Fourth Quarter and Full Year 2018 Financial Results on March 12, 2019
12/03/2019
REDWOOD CITY, Calif., March 11, 2019 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) today announced it will report financial results for the fourth quarter and full year 2018 after market close on Tuesday, March [...]
Bhang Corporation Announces Official Sponsorship of ICBC Barcelona After-Party Featuring Damian Marley
12/03/2019
ICBC Barcelona will take place on March 14th, 2019 at the Auditori de Cornellà, with Bhang’s sponsored after-party at the W Barcelona Hotel LOS ANGELES, March 12, 2019 (GLOBE NEWSWIRE) -- Bhang Corporation ("Bhang" or [...]
Trillium Therapeutics Reports Annual Financial and Operating Results
11/03/2019
Positive data from the intratumoral trial of TTI-621, a CD47 immune checkpoint inhibitor, presented at the 2018 EORTC CLTF and ASH 2018 meetings Encouraging signals of activity and tolerability data from the intravenous [...]
ERYTECH Provides Business Update and Reports Financial Results for Full Year 2018
11/03/2019
Conference call and webcast on Tuesday, March 12 th at 1:30 pm CET/8:30 am EDT TRYbeCA1, a pivotal Phase 3 trial for eryaspase in second line pancreatic cancer, now actively enrolling patients TRYbeCA2, a proof of [...]
ERYTECH publie ses résultats financiers et fait le point sur ses activités de l’exercice 2018
11/03/2019
Conférence téléphonique et webcast mardi 12 mars à 13h30 (heure de Paris) Recrutement en cours dans l’étude TRYbeCA1 de phase 3 avec eryaspase dans le traitement en seconde ligne du cancer du pancréas Début du [...]
Zosano Pharma Announces Presentation and Participation at the 31st Annual Roth Conference
11/03/2019
FREMONT, Calif., March 11, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that its chairman, president and chief executive officer, John [...]
Radius Health to Present at Cowen 39th Annual Healthcare Conference
11/03/2019
WALTHAM, Mass., March 11, 2019 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS), today announced that Jesper Høiland, President and CEO of the Company, will present a corporate update at the Cowen 39 th Annual [...]
Novavax to Host Conference Call to Discuss Fourth Quarter and Year-End 2018 Financial Results on March 18, 2019
11/03/2019
GAITHERSBURG, Md., March 11, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX) today announced it will report its fourth quarter 2018 financial and operating results prior to U.S. financial markets opening on Monday [...]
Oxford Immunotec Reports Fourth Quarter and Full Year 2018 Financial Results
11/03/2019
OXFORD, United Kingdom and MARLBOROUGH, Mass., March 11, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the "Company"), a global, high-growth diagnostics company, today announced fourth quarter and [...]
ShockWave Announces Closing of its Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
11/03/2019
SANTA CLARA, Calif., March 11, 2019 (GLOBE NEWSWIRE) -- ShockWave Medical, Inc. (“ShockWave”) (Nasdaq: SWAV), today announced the closing of its initial public offering of 6,555,000 shares of its common stock at an [...]
Résultats 2018 du HOOPP : tenir la promesse de pension offerte à nos membres
11/03/2019
La situation de capitalisation est de 121 % et l'actif net a augmenté à 79 milliards de dollars TORONTO, 11 mars 2019 (GLOBE NEWSWIRE) -- Le Healthcare of Ontario Pension Plan (HOOPP) a annoncé aujourd’hui que son actif [...]

Pages